1. Pink Sheet
  2. >>Market Access
  3. >>Pricing Debate

Medicare Price Negotiation Targeting Only Post-Exclusivity Drugs Proposed By Moderate House Democrats

 
• By Cathy Kelly

Legislation authorizing the US government to directly negotiate drug prices with manufacturers failed to pass in one key House committee as a trio of Democrats joined Republicans to vote against advancing the policy.   

Washington DC Capitol dome detail with waving american flag
Prospects For Controversial Negotiation Legislation Dimming in House; What Will Senate Propose?

Moderate Democrats are working against broad US government drug price negotiation legislation in the US House and some are urging instead a more narrow approach that would apply only to drugs with expired market exclusivity that are covered by Medicare Part B.

Reps

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Pricing Debate

More from Market Access